Posts tagged "Conversation"

A Conversation with Drs. Christopher Kinsinger and Henry Rodriguez about Sharing Proteomics Data

Last September, NCI’s Office of Cancer Clinical Proteomics Research convened a workshop of researchers and stakeholders in the field of proteomics to discuss ways to better share data about the structure and functions of proteins—a challenge facing the entire proteomics community. The meeting, held in Sydney, Australia, addressed establishing standards to ensure the quality of the data, particularly those generated by a technique known as mass spectrometry. A meeting report with recommendations for the field was recently published simultaneously in four journals simultaneously.
NCI Cancer Bulletin

A Conversation with the NCI Women Scientist Advisors

The NCI Women Scientist Advisors Committee hosted a career development luncheon January 12 at the annual NCI Intramural Scientific Investigators Retreat. The NCI Women Scientist Advisors are composed of representatives from NCI’s two internal (intramural) research groups, the Center for Cancer Research (CCR) and Division of Cancer Epidemiology and Genetics (DCEG). Representatives from DCEG, Drs. Katherine McGlynn and Mary Ward, talked with the NCI Cancer Bulletin about the Women Scientist Advisors’ role at NCI. CCR’s representatives are Drs. Ying Zhang, Brigitte Widemann, and Cheryl Ann Winkler.
NCI Cancer Bulletin

Conversation with Dr. Jane Perlmutter about the Role of Advocates in Cancer Research

Dr. Jane Perlmutter is a long-term breast cancer survivor involved in cancer advocacy, specifically cancer research advocacy. She started her career as an experimental cognitive psychologist at the University of Texas in Austin and later worked in a corporate environment. She now runs her own consulting company, Gemini Group. Dr. Perlmutter is a member of several cancer research advisory panels, including the Cancer and Leukemia Group B (CALGB) Breast Cancer Committee, Clinical Trials Transformation Consortium, and Translational Breast Cancer Research Consortium. She is also the lead advocate advisor for NCI’s I-SPY2 breast cancer clinical trial.
NCI Cancer Bulletin

A Conversation with Dr. Ted Trimble on NCI’s Center for Global Health

Dr. Ted Trimble was recently named director of NCI’s Center for Global Health, which was created earlier this year. Dr. Trimble was previously head of Gynecological Cancer Therapeutics in the Division of Cancer Treatment and Diagnosis (DCTD). NCI Director Dr. Harold Varmus cited Dr. Trimble’s leadership role in developing the trans-NCI International Clinical Trials Collaboration Working Group and other global health experiences as important to developing the new center.
NCI Cancer Bulletin

A Conversation with Matthew Zachary about the Young Adult Cancer Movement

In 1995, during his senior year of college, aspiring concert pianist Matthew Zachary was diagnosed with brain cancer and entered a cancer world geared toward the needs of children and older adults. A decade after emerging from the experience, he founded the I’m Too Young For This! Cancer Foundation (i[2]y), which serves as a “community of support” for young adults, survivors of childhood cancers, and caregivers. Through its Web site, cancer conferences, forums, and Stupid Cancer Radio Show, i[2]y has become one of the many voices championing the needs of young adults with cancer.
NCI Cancer Bulletin

A Conversation with Dr. Martha Linet on Cell Phone Use and Cancer Risk

The International Agency for Research on Cancer (IARC) published a synopsis of its forthcoming Monograph on the Evaluation of Carcinogenic Risks to Humans online June 22 in Lancet Oncology. The monograph classifies exposure to mobile phones as “possibly carcinogenic to humans.” Dr. Martha Linet, chief of the Radiation Epidemiology Branch in NCI’s Division of Cancer Epidemiology and Genetics, discusses the IARC working group’s decision and summarizes some of the ongoing research on mobile phones and cancer risk.
NCI Cancer Bulletin

Inside NCI: A Conversation with Dr. Lauren Wood

A senior clinical investigator in NCI’s Vaccine Branch discusses the most recent advances in immune-based therapies and how clinical trials are important to the work she does. She also highlights why Minority Cancer Awareness Week is important and why barriers to clinical trials participation among minority populations still exist.
NCI Cancer Bulletin

A Conversation with Dr. Angela Mariotto and Dr. Martin Brown on the Rising Costs of Cancer Care

A new study from researchers in NCI’s Division of Cancer Control and Population Sciences (DCCPS) published January 12 in the Journal of the National Cancer Institute projects that the cost of caring for the U.S. population of cancer patients and survivors will increase substantially over the next 10 years. The researchers used data on cancer incidence and survival and on care costs by phase of care to develop estimates of the overall cost of care. They found that even if medical costs, cancer incidence, and survival remain static, the rapid aging of the U.S. population will cause the overall cost of care to rise from $ 125 billion in 2010 to $ 158 billion by 2020. If costs of care rise by only 2 percent annually, the overall cost of cancer treatment would rise to $ 173 billion by 2020, an almost 40 percent increase over the course of 10 years. Dr. Angela Mariotto, lead author of the study, and Dr. Martin Brown, chief of the Health Services and Economics Branch in DCCPS, recently spoke about this looming issue and how to address it.
NCI Cancer Bulletin

A Conversation with Dr. Barry Kramer about Cancer Screening

The editor-in-chief of NCI’s Physician Data Query (PDQ) Screening and Prevention Editorial Board talks about the types of effective cancer screening tests available and the risks that are sometimes associated with cancer screening.
NCI Cancer Bulletin